OSEBX1 963,65+0,00 %
EQNR371,80+1,03 %
DNB280,60+0,97 %
MOWI205,40+1,18 %
Brent$111,25+0,77 %
Gold$4 581,70−1,03 %
USD/NOK9,2725+0,10 %
EUR/NOK10,8820+0,14 %
SPX7 209,01+0,00 %
NDX27 452,12+0,00 %
LIVE · 09:40 UTC

ZJAMP Group Co Ltd

002758 · Specialty Retail · China

Profile
Ticker002758
RIC002758.SZ
ISINCNE100002029
IssuerZJAMP Group Co Ltd
SectorConsumer Discretionary
IndustrySpecialty Retail
Sub-industryAgricultural Chemicals
HeadquartersHangzhou, China
Country of issuerChina (Mainland)
Founded1999-08-16
Employees6,242
Total share float248,201,418
Holders (C/S)26,238
AuditorPan-China CPA
CEO / managementMr. Weiyong Ye
Business Description

ZJAMP Group Co Ltd (formerly Zhejiang Huatong Pharmaceutical Co Ltd) is a China-based company mainly engaged in the business of agricultural materials, automobile trade circulation and integrated services. The Company is mainly engaged in the research and development, production and sales of fertilizers, pesticides, agricultural machinery and other agricultural materials. The Company also operates pharmaceuticals and serves a comprehensive platform for the production and life of urban and rural people.

ESG · Risk Indicators
Controversies score
Governance pillar
Social pillar
Insider trading score
Industry Substrate · Chemicals
Signals to watch
  • Feedstock spread (price - input cost) (leading)
  • Plant utilization rate (coincident)
  • End-market demand (auto, construction, agri) (leading)
  • Inventory destocking/restocking cycles (coincident)
  • Specialty volume growth (trend)
Geopolitical drivers
  • Energy/feedstock cost (Russia gas, Middle East oil) · exposure: high
  • Trade tariffs on chemical exports/imports · exposure: medium-high
  • Environmental regulation (EU REACH, US EPA) · exposure: high
  • Agricultural policy (subsidies, fertilizer demand) · exposure: medium for agri-chem
Industry KPIs
  • EBITDA margin % — 5-15% commodity; 15-25% specialty
  • Capex/sales % — watch trough vs peak
  • Plant utilization % — 82-92% healthy; <80% pressure
  • ROIC — 10%+ specialty; 6-10% commodity through cycle
  • Net debt / EBITDA — below 3.0x healthy; cyclical buffer
Full Analysis Pending

Detailed financial analysis, valuation snapshot, multi-period history, and AI narrative are pending — generated when this company is included in the next analysis batch. Profile data above is point-in-time as of 2026-04-30.